Peter I. CLARK
Warrington and Halton Teaching Hospitals NHS Foundation Trust · 47 works · 4,632 citations · h-index 23
Top works
- INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION
- Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer
- Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer
- A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.
- Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study Group
- The Clinical Pharmacology of Etoposide and Teniposide
- Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity.
- Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study
- The Average Body Surface Area of Adult Cancer Patients in the UK: A Multicentre Retrospective Study
- Hypersensitivity and cross-reactivity to cisplatin and analogues
- Stem Cell Factor in Combination With Filgrastim After Chemotherapy Improves Peripheral Blood Progenitor Cell Yield and Reduces Apheresis Requirements in Multiple Myeloma Patients: A Randomized, Controlled Trial
- Predicting etoposide toxicity: relationship to organ function and protein binding.
- Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
- A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity.
- Inhibition of Papain by N‐Acyl‐aminoacetaldehydes and N‐Acyl‐aminopropanones
- The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancer.
- Exposing patients with chronic, stable, exertional angina to placebo periods in drug trials.
- Continuing Clozapine Despite Neutropenia
- Pharmacological attempts to improve the bioavailability of oral etoposide
- Conversion of the Active‐Site Cysteine Residue of Papain into a Dehydro‐serine, a Serine and a Glycine Residue